#DaiIchiLifeHoldings

For the nine months ended March 2026, ordinary income was JPY 8,320.758 billion (6.1% YoY increase), ordinary profit was JPY 597.712 billion (7.2% YoY increase), and net income attributable to owners of parent for the quarter was JPY 370.344 billion (4.7% YoY increase).

Group adjusted profit for the third quarter of the fiscal year ending March 2026 was 422.2 billion yen (progress rate 90%), with the full-year forecast revised upward to 500 billion yen, and the dividend forecast increased to 52 yen per share.

Group basic profit for the FY2026 third quarter was JPY 455,593 million, a 5.0% increase year-over-year. Consolidated total assets were JPY 72,384.6 billion, up 4.0% year-over-year.

Ordinary income for the cumulative third quarter period of the fiscal year ending March 2026 was 488,819 million yen, increasing year-over-year. Individual insurance policies in force amounted to 66,728.8 billion yen, representing 97.1% compared to the same period last year. The solvency margin ratio stood at 831.8%.

Annualized premiums for Q3 FY2025 totaled JPY 1,401,702 million (YoY 113.6%), ordinary income was JPY 17,698 million, and the solvency margin ratio stood at 371.8%.

For the fiscal year ending March 2026, ordinary income is revised to JPY 11,067 billion (7.2% increase from previous forecast), ordinary profit to JPY 718 billion (2.6% increase), and net income attributable to owners of parent to JPY 408 billion (2.0% increase). The year-end dividend forecast is increased to JPY 28 per share.

Executive personnel changes and organizational restructuring within the Dai-ichi Life Group effective April 1, 2026. Newly established Domestic Insurance Business Owner and Asset Management Business Owner positions to strengthen organizational structure.

An additional trust contribution of 7 billion yen will be made on February 25, 2026, with plans to acquire up to 7 million shares from the market between February 25 and March 26, 2026.

6,000 shares of restricted stock to be issued on March 4, 2026, at an issue price of 1,467 yen per share, totaling 8,802,000 yen. The transfer restriction period is three years and the shares are scheduled to be granted to eligible directors, etc.

In January 2026, 4,733,800 common shares were acquired at a total price of 6,452,670,850 yen; cumulative shares acquired reached 61,060,500 shares with a cumulative acquisition amount of 71,958,107,000 yen.

A new shareholder benefit program will be established for domestic resident shareholders recorded in the shareholder registry as of March 31, 2026, owning 100 shares or more; the maximum QOLism points will also be revised upward.

Acquired 6,802,500 common shares for 8,485,650,900 yen from December 1 to December 31, 2025. As of December 31, 2025, the cumulative number of shares acquired is 56,326,700 shares, with a total acquisition cost of 65,505,436,150 yen.